Viral Inactivation Market Effect Factors Analysis, Technology Progress, Revenue and Forecast
The Global Viral Inactivation Market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.
(firmenpresse) - According to the new market research report & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) Global Forecast
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121427017
The global Viral Inactivation Market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into the solvent detergent method, pasteurization, and other methods. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light. Of these, the solvent detergent method segment accounted for the largest share of the global Viral Inactivation Market in 2015.
The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Of these, the vaccines and therapeutics application hold the highest share.
Browse and in-depth TOC on
72 Tables
70 Figures
154 Pages
By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.
Rapidly increasing pharmaceutical and biotechnology industries and the increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period (2016 A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important end user of viral inactivation products.
Request for Free Sample Report (at)
https://www.marketsandmarkets.com/requestsampleNew.asp?id=121427017
The Geographic Segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.
Major players in the Viral Inactivation Market include Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: sales(at)marketsandmarkets.com
Datum: 06.06.2019 - 06:15 Uhr
Sprache: Deutsch
News-ID 1549686
Anzahl Zeichen: 5647
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 06.06.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 1173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Viral Inactivation Market Effect Factors Analysis, Technology Progress, Revenue and Forecast
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
